Abbott Laboratories buy JPMorgan Chase & Co.
Start price
20.04.23
/
50%
€101.24
Target price
20.04.24
€111.01
Performance (%)
-0.75%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. During the runtime of the prediction for Abbott Laboratories the price only changed by -0.75%. Dividends of €1.96 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | 1.501% | 1.501% | -24.803% |
| iShares Core DAX® | 0,39 % | 0,15 % | 10,96 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % | -0,61 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % | 26,75 % |
| iShares S&P 500 | 1,31 % | -1,16 % | -0,04 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at JPMorgan Chase & Co. from $118.00 to $122.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten